Gyre Therapeutics Inc. (GYRE)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Dunbar Officer	$21.86	22,602	$494,170.13	1,153	2009-12-16	Filing
Musso Officer	$22.27	1,000	$22,269.00	2,799	2009-12-16	Filing
Musso Officer	$22.31	11,809	$263,426.91	2,799	2009-12-15	Filing
Bencherif Officer	$22.19	8,056	$178,723.97	7,735	2009-12-15	Filing
Bencherif Officer	$22.45	4,967	$111,503.19	7,735	2009-12-14	Filing
Bencherif Officer	$22.45	6,533	$146,658.01	12,702	2009-12-14	Filing
Bencherif Officer	$22.44	1,435	$32,205.71	19,235	2009-12-14	Filing
Debethizy Officer, Director	$22.28	15,391	$342,922.25	28,926	2009-12-15	Filing
Debethizy Officer, Director	$22.44	2,600	$58,340.10	44,317	2009-12-14	Filing
Musso Officer	$21.53	37,223	$801,262.30	2,799	2009-12-11	Filing
Brennan Officer	$20.90	94,759	$1,980,557.86	0	2009-12-11	Filing
Zorn Officer	$20.64	6,035	$124,585.33	0	2009-10-22	Filing
Zorn Officer	$21.00	91,898	$1,930,308.30	0	2009-10-21	Filing
Zorn Officer	$21.40	23,650	$506,147.84	0	2009-10-20	Filing
Zorn Officer	$22.68	5,800	$131,515.00	0	2009-10-19	Filing
Brennan Officer	$21.95	13,978	$306,798.93	0	2009-10-20	Filing
Brennan Officer	$22.68	5,800	$131,515.00	0	2009-10-19	Filing
Bvf Large Shareholder, Other	$23.60	374,000	$8,824,567.40	2,061,925	2009-10-16	Filing
Bvf Large Shareholder, Other	$23.60	108,000	$2,548,270.80	2,435,925	2009-10-16	Filing
Bvf Large Shareholder, Other	$23.60	156,400	$3,690,273.64	2,543,925	2009-10-16	Filing